A new alternative for intravenous lipid emulsion 20% w/w from superolein oil and its effect on lipid and liver profiles in an animal model

Mohd Haz Hairul Amran, Mohd Hanif Zulfakar, Mohd Fairuz Danik, Mohd Shakrie Palan Abdullah, Ahmad Fuad Shamsuddin

Research output: Contribution to journalArticle

Abstract

Purpose: Intravenous lipid emulsion (IVLE) was first used to prevent essential fatty acids deficiency. IVLE with α-tocopherol was reported to provide protection against parenteral nutrition-associated liver disease. This study aims to determine the optimal parameters and conditions in developing a physically stable IVLE from superolein palm oil (SoLE 20%) and its effect on lipid and liver profiles in an animal model. Methods: SoLE 20% was prepared using superolein oil and MCT oil (1:1), stabilized with egg lecithin and homogenized using a high pressure homogenizer. Mean droplet size was used as the response variable and was measured using laser diffraction and dynamic light scattering method. Physical stability at 4 °C, 25 °C and 40 °C storage temperatures were determined based on particle size and distribution, polydispersity index, zeta potential, viscosity, vitamin E contents and pH. Sterility and pyrogenicity were also investigated. Rabbits were administered with 1.0 g/kg SoLE 20% for 5 h and repeated daily for 3 days to investigate its effect on blood lipid and liver enzymes profile. Results: SoLE 20% was succesfully prepared using the optimized parameters of 800 psi, 7 cycles and 1.2 g lecithin. The IVLE prepared had a particle size of 252.60 ± 4.88 nm and was physically stable for 4 weeks at different storage temperatures. SoLE 20% had a high content of natural vitamin E, remained sterile and pyrogen free. It was also safe for intravenous administration and did not alter the blood lipid (p > 0.05) and liver enzymes profiles (p > 0.05) of the rabbits. Conclusion: The optimal parameters to develop a stable superolein based IVLE are 800 psi homogenization pressure, 7 homogenization cycles and using 1.2 g lecithin as the emulsifier. SoLE 20% is safe for intravenous administration and does not significantly alter lipid and liver enzymes profiles of the rabbits.

Original languageEnglish
Pages (from-to)191-201
Number of pages11
JournalDARU, Journal of Pharmaceutical Sciences
Volume27
Issue number1
DOIs
Publication statusPublished - 1 Jun 2019

Fingerprint

Intravenous Fat Emulsions
Oils
Animal Models
Lecithins
Lipids
Liver
Rabbits
Vitamin E
Particle Size
Intravenous Administration
Enzymes
Pyrogens
Pressure
Essential Fatty Acids
Temperature
Tocopherols
Parenteral Nutrition
Viscosity
Infertility
Ovum

Keywords

  • Egg lecithin
  • Intravenous lipid emulsion
  • MCT
  • Response surface methodology
  • Superolein palm oil

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

A new alternative for intravenous lipid emulsion 20% w/w from superolein oil and its effect on lipid and liver profiles in an animal model. / Amran, Mohd Haz Hairul; Zulfakar, Mohd Hanif; Danik, Mohd Fairuz; Abdullah, Mohd Shakrie Palan; Shamsuddin, Ahmad Fuad.

In: DARU, Journal of Pharmaceutical Sciences, Vol. 27, No. 1, 01.06.2019, p. 191-201.

Research output: Contribution to journalArticle

@article{76f19add71b24a91931c09813d7fde6b,
title = "A new alternative for intravenous lipid emulsion 20{\%} w/w from superolein oil and its effect on lipid and liver profiles in an animal model",
abstract = "Purpose: Intravenous lipid emulsion (IVLE) was first used to prevent essential fatty acids deficiency. IVLE with α-tocopherol was reported to provide protection against parenteral nutrition-associated liver disease. This study aims to determine the optimal parameters and conditions in developing a physically stable IVLE from superolein palm oil (SoLE 20{\%}) and its effect on lipid and liver profiles in an animal model. Methods: SoLE 20{\%} was prepared using superolein oil and MCT oil (1:1), stabilized with egg lecithin and homogenized using a high pressure homogenizer. Mean droplet size was used as the response variable and was measured using laser diffraction and dynamic light scattering method. Physical stability at 4 °C, 25 °C and 40 °C storage temperatures were determined based on particle size and distribution, polydispersity index, zeta potential, viscosity, vitamin E contents and pH. Sterility and pyrogenicity were also investigated. Rabbits were administered with 1.0 g/kg SoLE 20{\%} for 5 h and repeated daily for 3 days to investigate its effect on blood lipid and liver enzymes profile. Results: SoLE 20{\%} was succesfully prepared using the optimized parameters of 800 psi, 7 cycles and 1.2 g lecithin. The IVLE prepared had a particle size of 252.60 ± 4.88 nm and was physically stable for 4 weeks at different storage temperatures. SoLE 20{\%} had a high content of natural vitamin E, remained sterile and pyrogen free. It was also safe for intravenous administration and did not alter the blood lipid (p > 0.05) and liver enzymes profiles (p > 0.05) of the rabbits. Conclusion: The optimal parameters to develop a stable superolein based IVLE are 800 psi homogenization pressure, 7 homogenization cycles and using 1.2 g lecithin as the emulsifier. SoLE 20{\%} is safe for intravenous administration and does not significantly alter lipid and liver enzymes profiles of the rabbits.",
keywords = "Egg lecithin, Intravenous lipid emulsion, MCT, Response surface methodology, Superolein palm oil",
author = "Amran, {Mohd Haz Hairul} and Zulfakar, {Mohd Hanif} and Danik, {Mohd Fairuz} and Abdullah, {Mohd Shakrie Palan} and Shamsuddin, {Ahmad Fuad}",
year = "2019",
month = "6",
day = "1",
doi = "10.1007/s40199-019-00262-7",
language = "English",
volume = "27",
pages = "191--201",
journal = "Daru",
issn = "1560-8115",
publisher = "Teheran University of Medical Sciences",
number = "1",

}

TY - JOUR

T1 - A new alternative for intravenous lipid emulsion 20% w/w from superolein oil and its effect on lipid and liver profiles in an animal model

AU - Amran, Mohd Haz Hairul

AU - Zulfakar, Mohd Hanif

AU - Danik, Mohd Fairuz

AU - Abdullah, Mohd Shakrie Palan

AU - Shamsuddin, Ahmad Fuad

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Purpose: Intravenous lipid emulsion (IVLE) was first used to prevent essential fatty acids deficiency. IVLE with α-tocopherol was reported to provide protection against parenteral nutrition-associated liver disease. This study aims to determine the optimal parameters and conditions in developing a physically stable IVLE from superolein palm oil (SoLE 20%) and its effect on lipid and liver profiles in an animal model. Methods: SoLE 20% was prepared using superolein oil and MCT oil (1:1), stabilized with egg lecithin and homogenized using a high pressure homogenizer. Mean droplet size was used as the response variable and was measured using laser diffraction and dynamic light scattering method. Physical stability at 4 °C, 25 °C and 40 °C storage temperatures were determined based on particle size and distribution, polydispersity index, zeta potential, viscosity, vitamin E contents and pH. Sterility and pyrogenicity were also investigated. Rabbits were administered with 1.0 g/kg SoLE 20% for 5 h and repeated daily for 3 days to investigate its effect on blood lipid and liver enzymes profile. Results: SoLE 20% was succesfully prepared using the optimized parameters of 800 psi, 7 cycles and 1.2 g lecithin. The IVLE prepared had a particle size of 252.60 ± 4.88 nm and was physically stable for 4 weeks at different storage temperatures. SoLE 20% had a high content of natural vitamin E, remained sterile and pyrogen free. It was also safe for intravenous administration and did not alter the blood lipid (p > 0.05) and liver enzymes profiles (p > 0.05) of the rabbits. Conclusion: The optimal parameters to develop a stable superolein based IVLE are 800 psi homogenization pressure, 7 homogenization cycles and using 1.2 g lecithin as the emulsifier. SoLE 20% is safe for intravenous administration and does not significantly alter lipid and liver enzymes profiles of the rabbits.

AB - Purpose: Intravenous lipid emulsion (IVLE) was first used to prevent essential fatty acids deficiency. IVLE with α-tocopherol was reported to provide protection against parenteral nutrition-associated liver disease. This study aims to determine the optimal parameters and conditions in developing a physically stable IVLE from superolein palm oil (SoLE 20%) and its effect on lipid and liver profiles in an animal model. Methods: SoLE 20% was prepared using superolein oil and MCT oil (1:1), stabilized with egg lecithin and homogenized using a high pressure homogenizer. Mean droplet size was used as the response variable and was measured using laser diffraction and dynamic light scattering method. Physical stability at 4 °C, 25 °C and 40 °C storage temperatures were determined based on particle size and distribution, polydispersity index, zeta potential, viscosity, vitamin E contents and pH. Sterility and pyrogenicity were also investigated. Rabbits were administered with 1.0 g/kg SoLE 20% for 5 h and repeated daily for 3 days to investigate its effect on blood lipid and liver enzymes profile. Results: SoLE 20% was succesfully prepared using the optimized parameters of 800 psi, 7 cycles and 1.2 g lecithin. The IVLE prepared had a particle size of 252.60 ± 4.88 nm and was physically stable for 4 weeks at different storage temperatures. SoLE 20% had a high content of natural vitamin E, remained sterile and pyrogen free. It was also safe for intravenous administration and did not alter the blood lipid (p > 0.05) and liver enzymes profiles (p > 0.05) of the rabbits. Conclusion: The optimal parameters to develop a stable superolein based IVLE are 800 psi homogenization pressure, 7 homogenization cycles and using 1.2 g lecithin as the emulsifier. SoLE 20% is safe for intravenous administration and does not significantly alter lipid and liver enzymes profiles of the rabbits.

KW - Egg lecithin

KW - Intravenous lipid emulsion

KW - MCT

KW - Response surface methodology

KW - Superolein palm oil

UR - http://www.scopus.com/inward/record.url?scp=85068011428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068011428&partnerID=8YFLogxK

U2 - 10.1007/s40199-019-00262-7

DO - 10.1007/s40199-019-00262-7

M3 - Article

C2 - 31020546

AN - SCOPUS:85068011428

VL - 27

SP - 191

EP - 201

JO - Daru

JF - Daru

SN - 1560-8115

IS - 1

ER -